Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Notes Payables (2019 - 2021)

Historic Notes Payables for Silo Pharma (SILO) over the last 4 years, with Q3 2021 value amounting to $18900.0.

  • Silo Pharma's Notes Payables rose 16040.23% to $18900.0 in Q3 2021 from the same period last year, while for Sep 2021 it was $18900.0, marking a year-over-year increase of 16040.23%. This contributed to the annual value of $14654.0 for FY2020, which is 7631.68% down from last year.
  • According to the latest figures from Q3 2021, Silo Pharma's Notes Payables is $18900.0, which was up 16040.23% from $18900.0 recorded in Q2 2021.
  • Silo Pharma's 5-year Notes Payables high stood at $144375.0 for Q1 2020, and its period low was $7258.0 during Q2 2020.
  • For the 3-year period, Silo Pharma's Notes Payables averaged around $36382.1, with its median value being $18368.5 (2021).
  • Over the last 5 years, Silo Pharma's Notes Payables had its largest YoY gain of 16040.23% in 2021, and its largest YoY loss of 8764.54% in 2021.
  • Quarter analysis of 3 years shows Silo Pharma's Notes Payables stood at $61875.0 in 2019, then crashed by 76.32% to $14654.0 in 2020, then rose by 28.98% to $18900.0 in 2021.
  • Its Notes Payables was $18900.0 in Q3 2021, compared to $18900.0 in Q2 2021 and $17837.0 in Q1 2021.